SCHEMBL4756936

SCHEMBL4756936

O=C(O)Cc1nnc(-c2cc(Cl)cc(N3CCOCC3)c2)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 6/20 0.53
GAA P10253 1/20 0.43
PRKDC P78527 2/20 0.42
KDM4E B2RXH2 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 3/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
DGAT1 O75907 2/20 0.39
PIK3C2B O00750 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755677 0.88 CALCRL (0.54) CALCRLGAASMN1; SMN2MAPTDGAT1
SCHEMBL13985180 0.85 SMN1; SMN2 (0.53) CALCRLGAAKDM4ESMN1; SMN2HPGD
SCHEMBL4755125 0.84 TP53 (0.45) CALCRLKDM4ESMN1; SMN2HPGDMAPT
SCHEMBL4758257 0.82 RXRA (0.43) CALCRLNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL4758251 0.76 CALCRL (0.46) CALCRLNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL4757749 0.73 CALCRL (0.38) CALCRLSMN1; SMN2MAPTALDH1A1MEN1
Lithium SCHEMBL4757890 0.72 NOTUM (0.48) CALCRLSMN1; SMN2MAPTALDH1A1TSHR
SCHEMBL4757886 0.72 NOTUM (0.48) CALCRLSMN1; SMN2MAPTALDH1A1TSHR
SCHEMBL13985249 0.71 SMN1; SMN2 (0.49) CALCRLKDM4ESMN1; SMN2HPGDNPSR1
SCHEMBL4757784 0.70 CALCRL (0.53) CALCRLSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed